355 related articles for article (PubMed ID: 11256420)
1. The alloresponse.
Hernandez-Fuentes MP; Baker RJ; Lechler RI
Rev Immunogenet; 1999; 1(3):282-96. PubMed ID: 11256420
[TBL] [Abstract][Full Text] [Related]
2. Indirect allorecognition in solid organ transplantation.
Harris PE; Cortesini R; Suciu-Foca N
Rev Immunogenet; 1999; 1(3):297-308. PubMed ID: 11256421
[TBL] [Abstract][Full Text] [Related]
3. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
4. Rejection mechanisms in transplantation.
Game DS; Warrens AN; Lechler RI
Wien Klin Wochenschr; 2001 Oct; 113(20-21):832-8. PubMed ID: 11732119
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic response: allorecognition pathways.
Caballero A; Fernandez N; Lavado R; Bravo MJ; Miranda JM; Alonso A
Transpl Immunol; 2006 Dec; 17(1):3-6. PubMed ID: 17157204
[TBL] [Abstract][Full Text] [Related]
6. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
7. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
Watschinger B
Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
9. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
10. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.
Jiang S; Herrera O; Lechler RI
Curr Opin Immunol; 2004 Oct; 16(5):550-7. PubMed ID: 15341998
[TBL] [Abstract][Full Text] [Related]
11. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
12. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
13. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
14. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Hess AD
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
17. Indirect allorecognition: not simple but effective.
Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2008 Mar; 85(5):667-9. PubMed ID: 18337656
[TBL] [Abstract][Full Text] [Related]
18. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
19. Frontline: Peripheral priming of alloreactive T cells by the direct pathway of allorecognition.
Baratin M; Bonin K; Daniel C
Eur J Immunol; 2004 Dec; 34(12):3305-14. PubMed ID: 15484192
[TBL] [Abstract][Full Text] [Related]
20. Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand.
Spencer CT; Gilchuk P; Dragovic SM; Joyce S
Curr Opin Organ Transplant; 2010 Aug; 15(4):512-25. PubMed ID: 20616723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
